These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6356702)

  • 1. [Serum copper and manganese serum concentrations in uremia].
    Börner H; Mehnert E; Bruhn P; Hudec R
    Z Urol Nephrol; 1983 Aug; 76(8):544-8. PubMed ID: 6356702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of copper and manganese in serum in hemodialysis].
    Börner H; Mehnert E; Falkenhagen D; Hudec R; Klinkmann H
    Z Urol Nephrol; 1984 Aug; 77(8):483-9. PubMed ID: 6495897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The trace elements zinc and copper in chronic renal failure].
    Prehn B
    Z Urol Nephrol; 1988 Jan; 81(1):35-42. PubMed ID: 3364046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance.
    Moss AH; Solomons CC; Alfrey AC
    Proc Clin Dial Transplant Forum; 1979; 9():184-8. PubMed ID: 399505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-dialyzable manganese and copper levels in serum of patients with various diseases.
    Kanabrocki EL; Case LF; Graham L; Fields T; Miller EB; Oester YT; Kaplan E
    J Nucl Med; 1967 Mar; 8(3):166-72. PubMed ID: 6024130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Equivalence values of the antioxidative capacity in serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C; Popov I; Lewin G
    Z Urol Nephrol; 1990 Apr; 83(4):189-96. PubMed ID: 2378180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 receptor levels in end-stage renal disease and transplant patients.
    Di Stefano R; Carmellini M; Zucchelli G; Clerico A; Masini S; D'Elia F; Fossati N; Ambrogi F; Mosca F
    Transplant Proc; 1990 Aug; 22(4):1863-4. PubMed ID: 2389462
    [No Abstract]   [Full Text] [Related]  

  • 8. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis.
    Bustamante J; Martin Mateo MC; De Paula de Pedro A; Ortiz Manchado O
    Nephron; 1978; 22(4-6):312-5. PubMed ID: 740091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in lipid metabolism in uremia].
    Ianhez LE; Cruz O; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1976 Oct; 31(5):386-91. PubMed ID: 981882
    [No Abstract]   [Full Text] [Related]  

  • 12. Copper metabolism in uremia: effect of dialysis and zinc supplementation.
    Mahajan SK; Rye D; Sondheimer JH; McDonald FD
    Trans Am Soc Artif Intern Organs; 1985; 31():521-5. PubMed ID: 3837501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal insufficiency and hemostasis].
    Nieth H
    Thromb Diath Haemorrh; 1968; ():141-54. PubMed ID: 5726650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone levels in severe renal failure.
    Samaan NA; Freeman RM
    Metabolism; 1970 Feb; 19(2):102-13. PubMed ID: 5410941
    [No Abstract]   [Full Text] [Related]  

  • 16. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxycholecalciferol in Greek uremics.
    Drivas G; Bamias J; Tsomis A; Kalos A; Douratsos D; Melissinos K
    Invest Urol; 1980 Jul; 18(1):52-3. PubMed ID: 7410014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of extracorporeal dialysis on the blood copper concentration and its relation to the hemoglobin level in patients with chronic renal failure].
    Weyde W; Adamiec R
    Pol Tyg Lek; 1983 Jan; 38(2):51-4. PubMed ID: 6856498
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of magnesium in the clinical diagnostics of uremia].
    Schneider HJ; Anke M
    Acta Biol Med Ger; 1970; 25(3):502-8. PubMed ID: 5523116
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.